Human CYP3A4 and the metabolism of nefazodone and hydroxynefazodone by human liver microsomes and heterologously expressed enzymes

By Rotzinger S.   Baker G.B.  

European Neuropsychopharmacology, Vol. 12, Iss. 2, 2002-04 ,pp. : 91-100

Elsevier

Access to resources Recommend Favorite

Sex-dependent genetic markers of CYP3A4 expression and activity in human liver microsomes

By Schirmer Markus   Rosenberger Albert   Klein Kathrin   Kulle Bettina   Toliat Mohammad R   Nüürnberg Peter   Zanger Ulrich M   Wojnowski Leszek  

Pharmacogenomics, Vol. 8, Iss. 5, 2007-05 ,pp. : 443-453

Future Medicine

Access to resources Recommend Favorite

An Examination of IC50 and IC50-Shift Experiments in Assessing Time-Dependent Inhibition of CYP3A4, CYP2D6 and CYP2C9 in Human Liver Microsomes

By  

Drug Metabolism Letters, Vol. 2, Iss. 1, 2008-01 ,pp. : 51-59

Bentham Science Publishers

Access to resources Recommend Favorite

A Literature Review of Enzyme Kinetic Parameters for CYP3A4-Mediated Metabolic Reactions of 113 Drugs in Human Liver Microsomes: Structure- Kinetics Relationship Assessment

By  

Current Drug Metabolism, Vol. 7, Iss. 3, 2006-04 ,pp. : 231-249

Bentham Science Publishers

Access to resources Recommend Favorite

Association analysis of CYP2A6 genotypes and haplotypes with 5-fluorouracil formation from tegafur in human liver microsomes

By Wang Huijuan   Bian Ting   Liu Duan   Jin Tianbo   Chen Yong   Lin Aifen   Chen Chao  

Pharmacogenomics, Vol. 12, Iss. 4, 2011-04 ,pp. : 481-492

Future Medicine

Access to resources Recommend Favorite